So my dad's oncologist mentioned TTF therapy as something to consider alongside his current treatment plan, and I'll be honest, even with my NP background I had to do a lot of reading to understand what's actually happening here because it's not straightforward.
Basically, tumor treating fields (TTF) use low-intensity electric fields to disrupt cell division. The patient wears electrode pads under their clothing that connect to a portable device, and it runs continuously or for set hours per day depending on the protocol. For mesothelioma specifically, the evidence is still building, unlike with glioblastoma where it's been used longer and has more robust data.
What I've learned from talking to my dad's team: the theory is that the electric fields interfere with the microtubules during mitosis, so cancer cells can't divide properly. In pleural meso, this could theoretically slow progression or improve response to chemo, but I want to be clear that the clinical trial data for meso is not as extensive as people sometimes think. There are studies happening right now.
The practical side is what a lot of people don't talk about. The device is bulky. It requires daily electrode replacement because skin irritation happens. My dad's already dealing with fatigue from palliative care so adding another piece of equipment and maintenance felt overwhelming to us, honestly, and his oncologist at Northwestern was supportive either way.
If you're newly diagnosed and considering this, ask your team specifically about the trial data for your cell type and stage. Don't just go off the marketing materials. And talk about the daily management piece because that matters when you're already managing a lot.